Reversible dementia due to macroprolactinoma. Case report.
作者： Michael H. Brisman , Michael R. Fetell , Kalmon D. Post
DOI: 10.3171/JNS.1993.79.1.0135
关键词: Complication 、 Bromocriptine 、 Prolactinoma 、 Dopamine agonist 、 Cognitive disorder 、 Surgery 、 Macroprolactinoma 、 Adenoma 、 Dementia 、 Medicine
摘要: ✓ Subfrontal tumors are an infrequent cause of dementia. Most those that do dementia meningiomas, and the symptoms may recede when tumor is resected. A patient with a huge prolactinoma who came to medical attention because described. The shrank dramatically after bromocriptine therapy patient's mental status returned normal.
sci-hub.se 参考文章(19)
Kalmon D. Post, Paul C. McCormick, Jacqueline A. Bello, Differential diagnosis of pituitary tumors Endocrinology and Metabolism Clinics of North America. ,vol. 16, pp. 609- 645 ,(1987) , 10.1016/S0889-8529(18)30466-3
I. PELLEGRINI, R. RASOLONJANAHARY, G. GUNZ, P. BERTRAND, S. DELIVET, C. P. JEDYNAK, C. KORDON, F. PEILLON, P. JAQUET, A. ENJALBERT, Resistance to bromocriptine in prolactinomas. The Journal of Clinical Endocrinology and Metabolism. ,vol. 69, pp. 500- 509 ,(1989) , 10.1210/JCEM-69-3-500
Daniel L. Barrow, Junichi Mizuno, George T. Tindall, Management of prolactinomas associated with very high serum prolactin levels. Journal of Neurosurgery. ,vol. 68, pp. 554- 558 ,(1988) , 10.3171/JNS.1988.68.4.0554
Fred Y. Murphy, David L. Vesely, Richard M. Jordan, Stevenson Flanigan, Peter O. Kohler, Giant invasive prolactinomas The American Journal of Medicine. ,vol. 83, pp. 995- 1002 ,(1987) , 10.1016/0002-9343(87)90668-1
MICHAEL O. THORNER, RICHARD L. PERRYMAN, ALAN D. ROGOL, BRIAN P. CONWAY, ROBERT M. MACLEOD, IVAN S. LOGIN, J. LEON MORRIS, Rapid changes of prolactinoma volume after withdrawal and reinstitution of bromocriptine. The Journal of Clinical Endocrinology and Metabolism. ,vol. 53, pp. 480- 483 ,(1981) , 10.1210/JCEM-53-3-480
A M McGregor, M F Scanlon, R Hall, K Hall, Effects of bromocriptine on pituitary tumour size. BMJ. ,vol. 2, pp. 700- 703 ,(1979) , 10.1136/BMJ.2.6192.700
MICHAEL O. THORNER, WILLIAM H. MARTIN, ALAN D. ROGOL, J. LEON MORRIS, RICHARD L. PERRYMAN, BRIAN P. CONWAY, STUART S. HOWARDS, MARK G. WOLFMAN, ROBERT M. MACLEOD, Rapid regression of pituitary prolactinomas during bromocriptine treatment. The Journal of Clinical Endocrinology and Metabolism. ,vol. 51, pp. 438- 445 ,(1980) , 10.1210/JCEM-51-3-438
Jeffrey Cummings, D Frank Benson, Stephen LoVerme, Reversible dementia. Illustrative cases, definition, and review JAMA: The Journal of the American Medical Association. ,vol. 243, pp. 2434- 2439 ,(1980) , 10.1001/JAMA.243.23.2434
ANNA WARFIELD, DAVID M FINKEL, NORMAN J SCHATZ, PETER J SAVINO, PETER J SNYDER, Bromocriptine Treatment of Prolactin-Secreting Pituitary Adenomas May Restore Pituitary Function Annals of Internal Medicine. ,vol. 101, pp. 783- 785 ,(1984) , 10.7326/0003-4819-101-6-783
J A Wass, J Williams, M Charlesworth, D P Kingsley, A M Halliday, I Doniach, L H Rees, W I McDonald, G M Besser, Bromocriptine in management of large pituitary tumours. BMJ. ,vol. 284, pp. 1908- 1911 ,(1982) , 10.1136/BMJ.284.6333.1908